Experience with treatment of fifty eight Iraqi patients with Acute Myeloid Leukemia

Experience with treatment of fifty eight Iraqi patients with Acute Myeloid Leukemia

Background: Adults with Acute Myelogenous Leukemia (AML) have the lowest survival rate of all leukemias. Complete remission (CR) rate after induction therapy is about 55-85%, however 30% of patients fail to achieve remission and they remain alive only for about a year. Consolidation chemotherapy re...

Full description

Bibliographic Details
Main Author:	Khudhair A. AL-Khalissi
Format:	Article
Language:	English
Published:	Faculty of Medicine University of Baghdad 2014-01-01
Series:	مجلة كلية الطب
Subjects:	AML, induction, consolidation, OS, DFS.
Online Access:	http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/566

Similar Items

The profile of extremity and trunk soft tissue sarcoma in a tertiary referral center
by: Ahmed Mostafa Ahmed Mahmoud, et al.
Published: (2017-06-01)

C- Reactive protein and iron status in Iraqi patients with acute myeloid leukemia before and after treatment
by: Khitam Abdul Wahab Ali, et al.
Published: (2015-01-01)

A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
by: Roula Antoine Farah
Published: (2014-12-01)

Acute myeloid leukemia in the elderly : 159 Nagoya case studies
by: Nagura, Eiichi, et al.
Published: (1999)

A comparative study of bloodstream infections in acute myeloid leukemia according to different phases of treatment: Can we predict the organism?
by: Preetam Kalaskar, et al.
Published: (2017-01-01)

Expression of immune checkpoint molecules in Iraqi acute myeloid leukemia patients
by: Hassnien Samir Al-Hashemi, et al.
Published: (2021-01-01)

Acute Myeloid Leukemia: A Concise Review
by: Jennifer N. Saultz, et al.
Published: (2016-03-01)

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-08-01)

High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy
by: Hyelin Na, et al.
Published: (2019-11-01)

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
by: Amy Y. Wang, et al.
Published: (2018-01-01)

Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia
by: Dou L, et al.
Published: (2019-06-01)

Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
by: Xiaoyan Liu, et al.
Published: (2019-10-01)

Assessing clonal diversity in acute myeloid leukemia
by: Christensen, Weston Daniel
Published: (2016)

Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
by: Lim MY, et al.
Published: (2014-05-01)

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
by: Nestor R. Ramos, et al.
Published: (2015-04-01)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01)

Emerging therapies for acute myeloid leukemia
by: Caner Saygin, et al.
Published: (2017-04-01)

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)
by: Maryam Nourizadeh, et al.
Published: (2014-11-01)

Alternative Donor Transplantation for Acute Myeloid Leukemia
by: Nelli Bejanyan, et al.
Published: (2015-06-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
by: Bogdan Popescu, et al.
Published: (2019-12-01)

Role of the SUMO pathway in Acute Myeloid Leukemias response to treatments
by: Baik, Hayeon
Published: (2017)

HOTAIR expression and prognostic impact in acute myeloid leukemia patients
by: Rawda Ahmed Alaa Eldin, et al.
Published: (2021-05-01)

Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid Leukemia
by: Matthew R. Lordo, et al.
Published: (2021-01-01)

RSK Isoforms in Acute Myeloid Leukemia
by: Minyoung Youn, et al.
Published: (2021-06-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
by: Susanne Hofmann, et al.
Published: (2019-02-01)

Effect of Wuguteng tablets in the treatment of acute myeloid leukemia
by: Hai-Yan Ren, et al.
Published: (2017-01-01)

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin
by: Hien K Duong, et al.
Published: (2009-05-01)

Lymphoid associated antigen expression in new cases of Acute Myeloid Leukemia
by: R Jha, et al.
Published: (2013-10-01)

Translocation ETS leukemia-acute myeloid leukemia 1 (TEL-AML1) gene fusion in childhood acute lymphoblastic leukemia
by: Sri Mulatsih, et al.
Published: (2009-10-01)

Cytogenetics and molecular markers of acute myeloid leukemia from a tertiary care center in Saudi Arabia
by: Abdulaziz I Alrajeh, et al.
Published: (2017-01-01)

Does Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?
by: Zohreh Sanaat, et al.
Published: (2014-09-01)

Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-05-01)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
by: Jabra Zarka, et al.
Published: (2020-06-01)

Outcome After Azacitidine Treatment in Patients with High-Risk Myeolodysplastic Syndrome, Chronic Myelomonocytic Leukemia Type 2 and Acute Myeloid Leukemia – A Single Center Experience (Preliminary Data)
by: Varbanova V., et al.
Published: (2020-11-01)

Acute Myeloid Leukemia—Genetic Alterations and Their Clinical Prognosis
by: Francisco Alejandro Lagunas-Rangel, et al.
Published: (2016-07-01)

The clinical significance of γ-catenin in acute myeloid leukemia
by: Xu J, et al.
Published: (2016-06-01)

The Multidrug Resistance and Apoptosis Evaluation in Acute Myeloid Leukemia Cells After the In Vitro Doxorubicin Treatment
by: Karolína Jankovičová, et al.
Published: (2004-01-01)

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain
by: Arenaza A, et al.
Published: (2019-11-01)

Association of Hepatitis Virus on Acute and Chronic Myeloid Leukemias. A pilot Study
by: Abolfazl Movafagh, et al.
Published: (2012-09-01)